Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA

References

• Kallenberg C. G. M., Rarok A., Stegeman C. A., Limburg P. C. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody‐associated vasculitis. Autoimmun Rev 2002; 1: 61–6
   PubMedGoogle Scholar
• Heeringa P., Huugen D., Cohen Tervaert J. W. Anti‐neutrophil autoantibodies and leukocyte‐endothelial interaction: a sticky connection?. Trends Immunol 2005; 26: 561–4
   PubMed Web of Science ®Google Scholar
• Baslund B., Segelmark M., Wiik A., Szpirt W., Petersen J., Wieslander J. Screening for anti‐neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?. Clin Exp Immunol 1995; 99: 486–92
   PubMed Web of Science ®Google Scholar
• Savige J., Gillis D., Benson E., et al. International Consensus Statement on Testing and Reporting of ANCA. Am J Clin Pathol 1999; 111: 507–13
   PubMed Web of Science ®Google Scholar
• Trevisin M., Neeson P., Savige J. The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3‐ANCA) varies in different ELISAs. J Clin Pathol 2004; 57: 303–8
   PubMed Web of Science ®Google Scholar
• Westman K. W., Selga D., Bygren P., Segelmark M., et al. Clinical evaluation of a capture ELISA for detection of proteinase‐3 antineutrophil cytoplasmic antibody. Kidney Int 1998; 53: 1230–6
   PubMed Web of Science ®Google Scholar
• Csernok E., Holle J., Hellmich B., et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology 2004; 43: 174–80
   PubMed Web of Science ®Google Scholar
• International Accreditation New Zealand (IANZ). IANZ Standard NZS/ISO 15189:2003 (Medical Laboratories – Particular requirements for quality and competence). IANZ, Auckland 2003
   Google Scholar
• Gibson A., Stamp L. K., Chapman P. T., O'Donnell J. L. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology 2006; 45: 624–8
   PubMed Web of Science ®Google Scholar
• Witko‐Sarsat V., Halbwachs‐Mecarelli L., Almeida R. P., et al. Characterisation of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti‐neutrophil cytoplasmic autoantibodies. FEBS Lett 1996; 382: 130–6
   PubMed Web of Science ®Google Scholar
• van Rossum A. P., van der Geld Y. M., Limberg P. C., Kallenberg C. G. Human anti‐neutrophil cytoplasmic autoantibodies to proteinase 3 (PR3‐ANCA) bind to neutrophils. Kidney Int 2005; 68: 537–41
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J. W., van der Woude F. J., Fauci A. S., et al. Association between active WG and cytoplasmic antibodies. Arch Intern Med 1989; 149: 2461–5
   PubMedGoogle Scholar
• Jayne D. R. W., Gaskin G., Pusey C. D., Lockwood C. M. ANCA and predicting relapse in systemic vasculitis. QJM 1995; 149: 1–15
   Google Scholar
• Cohen Tervaert J. W., Huitema M. G., Hené R. J., et al. Prevention of relapses in Wegener's granulomatosis by treatment based and antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709–11
   PubMed Web of Science ®Google Scholar
• Boomsma M. M., Stegeman C. A., van der Leij M. J., et al. Prediction of relapses in WG by measurement of ANCA levels. Arthritis Rheum 2000; 43: 2025–33
   PubMed Web of Science ®Google Scholar
• Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titre in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365–71
   PubMed Web of Science ®Google Scholar
• Esser P. 1988. Principles in adsorption to polystyrene. Nunc Laboratories Bulletin. 6. 317-21. http://www.nuncbrand.com/page/en/579.aspx, accessed Oct 2006
   Google Scholar
• Specks U. 2000. What you should know about PR3‐ANCA conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition of PR3‐ANCA. Arthritis Res. 2. 263-7. http://arthritis‐research.com/content/2/4/263, accessed Oct 2006
   Google Scholar
• Fujinaga M., Chernaia M. M., Halenbeck R., Koths K., James M. N. G. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol 1996; 261: 267–78
   PubMed Web of Science ®Google Scholar
• Gissen K., Wieslander J., Westberg G., Herlitz H. Relationship between anti‐neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long‐term clinical course in vasculitis. J Int Med 2002; 251: 129–35
   PubMed Web of Science ®Google Scholar